IP Library Granted Patent US 12674142
Granted Patent B2
US 12674142 · App. 18/033,536 · Granted Jul 7, 2026

Hydrogel compositions and methods of use thereof

Inventors: Sarah Heilshorn (Mountain View, CA); Riley Suhar (Redwood City, CA); Daniel Hunt (Redwood City, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
C12N5/0679C12N5/0012C12N2509/00C12N2513/00C12N2533/50C12N2533/80C12N2537/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12674142
App. No.
18/033,536
Granted
Jul 7, 2026
Kind
B2
Abstract

A two-component hydrogel matrix system is provided, which system is useful in a variety of cell growth uses, including without limitation three-dimensional culture systems. The components comprise modified hyaluronic acid (HA); and modified elastin-like proteins (ELP). Variables of HELP, including for example, matrix stiffness, matrix stress relaxation rate, and cell-adhesive-ligand concentration, can be independently and quantitatively specified.

Claims (20)

1 . A two-component hydrogel matrix system comprising: a first component comprising a defined ratio of hyaluronic acid (HA) modified to comprise a pendant reactant group benzaldehyde; and a second component comprising an elastin-like protein (ELP) modified to comprise a pendant reactant group hydrazine group; wherein cross-links between the first component and the second component are formed to generate a hydrogel upon mixing.

2 . The system of claim 1 , wherein matrix stiffness is independently tuned by varying the ratio of the reactant groups present on the first component, to reactant groups present on the second component.

3 . The system of claim 1 , wherein the ratio of reactant groups is varied by one or more of: specifying the number of reactant groups on HA; specifying the number of reactant groups on ELP; and specifying the ratio of HA:ELP.

4 . The system of claim 1 , wherein the ELP comprises from 1 to 7 elastin-like motifs.

5 . The system of claim 4 , wherein the elastin-like motifs are selected from SEQ ID NO:23, 24 and 25.

6 . The system of claim 1 , wherein the ELP comprises a cell adhesive domain from 15 to 45 amino acids in length, comprising one or more cell adhesion sequence motifs, or scrambled or lacking RGD.

7 . The system of claim 6 , wherein the cell adhesion motifs are selected from RGD or any of SEQ ID NO:3 to SEQ ID NO:9.

8 . The system of claim 1 , wherein the ELP comprises one or both of SEQ ID NO: 1 and SEQ ID NO:2.

9 . The system of claim 1 , wherein the cell-adhesive peptide concentration of the hydrogel is tuned by varying the ratio of ELP comprising a cell adhesive motif to ELP lacking a cell-adhesive motif.

10 . The system of claim 7 , wherein the ratio of ELP comprising a cell adhesive motif to ELP lacking a cell-adhesive motif is from 100:0 to 0:100.

11 . The system of claim 1 , wherein the ELP comprises from 3 to 20 hydrazine groups.

12 . The system of claim 1 , wherein the hydrogel comprises up to about 1.5 mM RGD.

13 . A hydrogel formed from the system of claim 1 .

14 . A method of culturing a mammalian cell, the method comprising encapsulating an initiating population of mammalian cells in a hydrogel of claim 13 , and maintaining the encapsulated cells in a suitable medium.

15 . The method of claim 14 , wherein the initiating cell population comprises a single cell suspension or a tissue explant.

16 . The method of claim 14 , wherein the cell population comprises stem cells.

17 . The method of claim 14 , wherein the initiating cell population differentiates into organoids in culture.

18 . The method claim 14 , wherein encapsulated cells are passaged by enzymatically degrading the hydrogel.

19 . The system of claim 1 , wherein the molecular weight of the HA is from 20 kDa to 100 kDa.

20 . The method of claim 16 , wherein the stem cells comprise epithelial cells.